HERG Screening Market Highlights

HERG Screening Market size report has estimated at USD 0.9 billion in 2022. The market for HERG screening is anticipated to increase from USD 1.0 billion in 2023 to USD 2.6 billion by 2032, with a compound annual growth rate (CAGR) of 12.50% over the course of the forecast period (2023-2032).

Dive into the enthralling world of HERG Screening, where the pursuit of safer medications and a healthy future is front and centre. The HERG Screening Market is a dynamic innovation hub focused on identifying and managing potential cardiac hazards associated with drug development. The requirement for comprehensive screening technologies to detect harmful effects on cardiac ion channels is increasing as pharmaceutical research accelerates.

This market is primed for tremendous growth, thanks to cutting-edge technology and an increasing emphasis on precision medicine. It's not just about protecting patients' health; it's also about opening the path for game-changing pharmacological advances.

Join us as we navigate the complex world of HERG Screening, where chances for investors and healthcare visionaries abound, promising not only financial gain but also a safer future for all.

Segment Analysis

Global HERG Screening Market is segmented into Type, i.e., gene KCNH2 and mutant KCNH2. KCNH2 gene that provides guidelines for producing potassium channels and held the largest market share in the HERG screening market. The global HERG screening market is segmented based on ion channel, further bifurcated into voltage-gated ion channel, ligand-gated ion channel, and others. Voltage-gated ion channel held the largest share in the HERG screening market, whereas ion-gated channel is the fastest-growing segment. The application segment is divided into antiarrhythmic drugs, antipsychotics, antibiotics, and others. The antiarrhythmic drug application segment is projected to account for a considerable market share.

Regional Analysis

The global HERG screening market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East Africa.

The Americas has been segmented into North America and Latin America, with the North America market further divided into the US and Canada. The Americas held the largest share of the HERG screening market. This share can be attributed to technological development and the high prevalence of cardiac disease in the region.

The Europe HERG screening market has been segmented into Western Europe and Eastern Europe. The Western Europe HERG screening market has further been classified into Germany, France, the UK, Italy, Spain, and the Rest of Western Europe. The major players of these countries are involved in new launches and acquisitions in the HERG screening market. The HERG screening market in Asia-Pacific has been segmented into China, India, Japan, South Korea, Australia, and the Rest of Asia-Pacific. The market growth in these countries is attributed to the large pool of patients suffering from cardiac disorders and the need for drug formulation and development to cure these disorders. The Middle East Africa HERG screening market has been divided into the Middle East and Africa.

Key Players

MRFR recognizes the following companies as the Key players in its HERG Screening Market overview report —Thermo Fisher Scientific, Eurofins Discover X Corporation, Charles River Laboratories, Merck KGaA, Metrion Biosciences Ltd, and Aurora Biomed, Inc.

Key Findings of the Study

  • HERG Screening Market is expected to register a CAGR of 12.50% during the assessment period of 2023 to 2032.
  • The Americas accounted for the largest share of the global HERG screening market due to the presence of prominent players in the US, high uptake rate, and product clearances from regulatory authorities.
  • Based on type, the KCNH2 gene segment accounted for the largest market share.
  • On the basis of ion channel, the voltage-gated ion channel segment is expected to be the fastest-growing segment during the forecast period.
  • Based on application, the antiarrhythmic drug segment is expected to be the largest and fastest-growing segment during the forecast period.

About Market Research Future:

Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Contact Us:

Market Research Future (Part of Wantstats Research and Media Private Limited)

99 Hudson Street, 5Th Floor

New York, NY 10013

United States of America

+1 628 258 0071 (US)

+44 2035 002 764 (UK)

Email: sales@marketresearchfuture.com

Website: https://www.marketresearchfuture.com